SSRI Lawsuit
Lawsuits have been filed against SSRI manufacturers alleging that prenatal exposure causes birth defects and that manufacturers failed to adequately warn pregnant women and healthcare providers.
SSRI Birth Defects Litigation
Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed antidepressants used to treat depression and anxiety. Scientific research has linked prenatal SSRI exposure to increased risk of birth defects, including congenital heart defects, cleft palate, and persistent pulmonary hypertension.
Lawsuits have been filed alleging that SSRI manufacturers knew about birth defect risks but failed to adequately warn healthcare providers and pregnant women.
Prenatal SSRI Exposure
Many pregnant women took SSRIs to manage depression and anxiety during pregnancy. Some SSRIs have been associated with increased birth defect risk when taken during the first trimester, a critical period of fetal development.
Infants born to mothers who took SSRIs have experienced congenital heart defects, cleft lip and palate, and other serious birth defects requiring surgical correction and ongoing medical care.
Congenital Heart Defects
Some SSRI medications have been linked to increased risk of specific congenital heart defects including septal defects, valve abnormalities, and other cardiac malformations. These defects often require surgical repair.
The timing of SSRI exposure during pregnancy is critical, with greatest risk during the first trimester when the fetal heart is developing.
Inadequate Warning and Counseling
Manufacturers failed to adequately warn healthcare providers and pregnant women about birth defect risks associated with SSRI use during pregnancy. Prescribing information was not sufficiently prominent regarding risks.
Healthcare providers were not adequately informed to discuss birth defect risks with pregnant women and consider alternative treatments or drug discontinuation.
Who May Qualify for a Claim
Children born with congenital birth defects whose mothers took SSRIs during pregnancy may have viable claims. Infants with documented heart defects, cleft palate, or other SSRI-associated defects may support claims.
To evaluate your case, we need information about the SSRI medication used, the timing of exposure during pregnancy, the birth defect diagnosis with medical documentation, and medical records relating to the child's condition and treatment.
Free Case Review
If you or a family member may have a SSRI birth defect claim, MDLaw Firm can evaluate your claim based on your exposure history and medical records.
Start Your ReviewNo fees. No commitments. Confidential.
Key Facts
- Product: SSRI Antidepressants
- Status: Ongoing Litigation
- Injuries: Congenital heart defects, cleft palate, birth defects
- Evidence: SSRI exposure history, birth defect diagnosis, medical records, imaging studies
No attorney-client relationship is created by reading this page. Case results depend on specific facts. Consult an attorney for advice specific to your situation.